UAE Medicinal Product Registration Process | EDE Requirements Guide

How to Register Medicinal Products in the UAE: EDE Process and Requirements

2 min read

The Emirates Drug Establishment (EDE) is the primary authority responsible for medicinal product registration in the UAE. Any medicinal product must receive EDE approval before it can be imported, marketed, or distributed in the United Arab Emirates.

The process is designed to ensure that all medicines meet stringent standards for quality, safety, and efficacy, aligned with international Regulatory frameworks.

Overview of the EDE Medicinal Product Registration Process

The EDE drug registration process for medicinal products follows a structured, digital-first approach:

Company & Local Authorization
The applicant (Marketing Authorization Holder) must be registered with EDE and operate through a licensed local entity or medical warehouse / drug store.
Dossier Preparation (eCTD Format)
A complete dossier must be submitted in eCTD format, including:
- Administrative Module
- Quality (CMC) data including stability data along with the raw data
- Non-clinical studies
- Clinical data including Bioequivalence (BE) study, if applicable

Both Stability section and BE section are critically important in pharmaceutical product registration in the UAE.

Online Submission via MOHAP Portal
Applications are submitted through MOHAP’s digital platform, ensuring transparency and faster processing.
Scientific Evaluation & Testing
EDE conducts a detailed assessment of:
- Quality, safety, and efficacy
- Stability and bioequivalence
- Risk-benefit profile

Laboratory testing and expert committee reviews may be conducted as part of the evaluation.

Pricing Approval
Before approval, the product undergoes pricing evaluation by EDE’s pricing committee.
Final Approval & Registration
Upon successful evaluation:
- Marketing authorization is granted
- A registration certificate is issued (typically valid for five years)

Timelines for Medicinal Product Registration

The standard timeline for drug registration in the UAE is approximately 3 – 6 months for a complete, well-prepared dossier. Registration time may be extended depending on query resolution.

Key Challenges in EDE Medicinal Product Registration

While the process is well-defined, companies often face challenges when navigating the UAE pharmaceutical Regulatory requirements:

Dossier Complexity and Compliance
Preparing a complete and compliant eCTD dossier that meets EDE expectations can be resource-intensive and technically demanding.
Local Representation Requirements
Foreign manufacturers must work through authorized local entities, which can add coordination and compliance complexity.
Regulatory Variability and Updates
Frequent updates to guidelines and digital systems require continuous Regulatory monitoring and adaptation.
Pricing Constraints
EDE pricing regulations can impact market strategy and profitability, especially for innovative or niche products.
Query Management and Timelines
Delays in responding to Regulatory queries can extend approval timelines significantly.

Post-Approval Requirements

After approval, companies must comply with:

Pharmacovigilance obligations
Post-approval variations
Renewal of registration every five years

These ensure ongoing compliance and product safety in the UAE market.

Conclusion

The EDE medicinal product registration process is robust, structured, and increasingly efficient. However, success depends on strong Regulatory planning, high-quality submissions, and proactive compliance management.